Fachliteratur zum Bestellen und zum Download

Hier finden Sie

  • Online-Publikationen
  • aktuelle Fachliteratur
  • Downloads

zu rechtlichen, wirtschaftlichen und steuerlichen Themen im Gesundheitswesen. Dieser Shop bietet Ihnen aus allen relevanten Fachverlagen über 1.000 ausgewählte Publikationen.

A systematic approach to decision-making

Benefit-Risk Appraisal of Medicines

A systematic approach to decision-making

Written by renowned experts in the field, this book establishes the criteria required to assess benefit-risk in general and reviews the current practice of benefit-risk assessment by drug regulatory authorities and the pharmaceutical industry. It outlines how the new MCDA model was developed and evaluated, and discusses the implications of its implementation into the practice of drug evaluation. Comparisons are also made with existing benefit-risk models such as the 'Principle of Threes' and TURBO models.

* Discusses a very topical subject in the wake of the withdrawal of the Cox-2 inhibitors and other high-profile withdrawals

* Includes risk-management plans

* New MCDA model is relevant for the assessment of both, new compounds being presented for licence and the ongoing evaluation of existing drugs on the market

* MCDA model allows for all available efficacy and safety data to be evaluated

 

Risk/Benefit Assessment in Medicine is an invaluable resource for researchers, clinical trial managers, pharmacovigilance and epidemiology staff in the pharmaceutical industry. The book is also useful for drug regulatory authorities, and pharmaceutical medicine or medicinal chemistry departments at universities.

Verlag:
Wiley-Blackwell
Autor:
Mussen, Filip / Salek, Sam / Walker, Stuart
Jahr:
2009
Preis:
77,90 €
Seiten:
304 Seiten, Hardcover
ISBN:
978-0-470-06085-8